Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: All you need to know about Johnson & Johnson’s Q1 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2023 earnings results today.
Reported sales increased 5.6% year-over-year to $24.7 billion.
On a GAAP basis, the company reported net loss of $68 million, or $0.03 per share, compared to net income of $5.1 billion, or $1.93 per share, last year. Adjusted EPS was $2.68.
Both revenue and adjusted EPS beat expectations.
For the full year of 2023, the company expects adjusted operational sales to grow 4.5-5.5% year-over-year.
Prior performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
